Clinical Trials
3 trialsNCT02367547 2019-03-28
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
Joint Authority for Päijät-Häme Social and Health Care
Phase 1/2 Unknown
NCT01482104 2017-10-27
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
Norwegian University of Science and Technology
Phase NA Completed
NCT01491711 2014-01-31
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
Maastricht University Medical Center
Phase 4 Unknown